Assist. Prof. Özlem Apti Şengkioun is a board-trained dermatologist with specialized training from Marmara University Faculty of Medicine, where she completed her Dermatology and Venereology education in 2022. She currently practices with Acıbadem Health Group, bringing evidence-based care and a patient-centered approach to medical and cosmetic dermatology. An active member of the professional community, she holds memberships in the European Academy of Dermatology and Venereology, the Turkish Dermatology Association, and the Skin and Venereal Diseases Association. Her clinical interests include inflammatory skin disorders, dermatologic surgery, and the integration of new therapies and technologies to improve patient outcomes. Known for clear communication and compassionate care, Assist. Prof. Özlem emphasizes individualized treatment plans and continuing professional development to stay current with advances in dermatology.
Education
- 2022 Marmara University Faculty of Medicine Dermatology and Venereology
- 2017 Istanbul University Cerrahpasa Faculty of Medicine
Experience
- 2024 Acibadem Health Group
- 2023 Acibadem Health Group
- 2018 – 2022 Marmara University Faculty of Medicine / Department of Skin and Venereal Diseases /
Memberships
- European Academy of Dermatology and Venereology
- Turkish Dermatology Association
- Skin and Venereal Diseases Association
Publications
- A review of comorbidities of Atopic dermatitis
Indian Journal of Skin Allergy doi: 10.25259/IJSA_37_2024 July 24 Apti Sengkioun, O., Salman A. - Endothelial dysfunction, thrombophilia, and nailfold capillaroscopic features in livedoid vasculopathy
Microvasc Res. 2023 Aug 4;150:104591. doi: 10.1016/j.mvr.2023.104591. Epub ahead of print. PMID: 37543163. Apti Sengun O, Ergun T, Guctekin T, Alibaz Oner F. - Immunogenicity, efficacy, and safety of CoronaVac and Pfizer/BioNTech mRNA vaccines in patients with psoriasis receiving systemic therapies: A prospective cohort study
Vaccine. 2023 Jun 29;41(29):4287-4294. doi: 10.1016/j.vaccine.2023.05.052. Epub 2023 Jun 3. PMID: 37277251; PMCID: PMC10239265. Ergun T, Hosgoren Tekin S, Apti Sengun O, Akin Cakici O, Seckin D, Adiay C, Enul H, Yilmaz S, Ay P, Haklar G, Sili U. - Real-life effectiveness and safety of dupilumab in adult patients with moderate-to-severe atopic dermatitis.
Dermatol Ther. 2022 Jan;35(1):e15192. doi: 10.1111/dth.15192. Epub 2021 Nov 15. PMID: 34743366 Salman A, Apti Sengun Ö, Aktas M, Taskapan O. - Evaluation of capillaroscopic findings and endothelial dysfunction in patients withivedoid vasculopathy.
Tıpta Uzmanlık Tezi, 2022, İstanbul Apti Sengun, Ozlem. - Remission of chronic spontaneous urticaria following omalizumab with gradually extended dosing intervals: Real-life data.
Australas J Dermatol. 2021 Aug;62(3):398-402. doi: 10.1111/ajd.13656. Epub 2021 Jun 22. PMID: 34156714. Salman A, Aktas M, Apti Sengun O. - Yellow Urticaria. The Journal of Allergy and Clinical Immunology
In Practice, 9(1), 479?480. doi:10.1016/j.jaip.2020.10.029 Çakıcı, Ö. A., Sengün, O. A., Tekin, S. H., & Salman, A. - Netherton syndrome: Temporary response to dupilumab.
. Pediatr Dermatol. 2020 Nov;37(6):1210-1211. doi: 10.1111/pde.14362. Epub 2020 Sep 19. PMID: 32951242. Aktas M, Salman A, Apti Sengun O, Comert Ozer E, Hosgoren Tekin S, Akin Cakici O, Demir G, Ergun T. - Slime A trending cause of isothiazolinone contact allergy in children
Contact Dermatitis. doi:10.1111/cod.13237 Salman, A., Demir, G., & Apti, O.
